MTI013
Product Specifications
Target
Opioid Receptor, SARS-CoV
Related Pathways
GPCR/G Protein, Endocrinology/Hormones, Neuroscience, Microbiology/Virology
Bioactivity
MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 μM) and an antiviral agent (IC50: 10.33 μM in HCoV-229E infected Huh7 cells) . Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.
Smiles
O=C(C1=CC(CSC[C@H]2[C@H](O)[C@@H](O)[C@H](N3C(N=CN=C4N)C4N=C3)O2)=CC=C1)NC5=CC=CC=C5
Molecular Formula
C24H26N6O4S
Molecular Weight
494.57
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9020477-01 0.02 mg (E-Coli)
Recombinant Gnathostoma spinigerum Matrix metalloproteinase-like protein
Sign In for Pricing
View Details MBS9020477-02 0.1 mg (E-Coli)
Recombinant Gnathostoma spinigerum Matrix metalloproteinase-like protein
Sign In for Pricing
View Details MBS9020477-03 1 mg (E-Coli)
Recombinant Gnathostoma spinigerum Matrix metalloproteinase-like protein
Sign In for Pricing
View Details MBS9020477-04 5x 1 mg (E-Coli)
Recombinant Gnathostoma spinigerum Matrix metalloproteinase-like protein
Sign In for Pricing
View Details